Octavio Espinoza is CFO at LIGAND PHARMACEUTICALS INC (LGND). They have made 10 open-market trades across 1 company since 2022, most recently 2026-08-12.
CIK 0001905248
1 open-market purchase totalling $156K since 2025, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LGND | 27,696 | $8.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LGND | SELL · 10b5-1 | 2026-08-12 | 2026-08-14 | $292.07 | $9.2M | -2.6% | -4.9% | — |
| LGND | SELL | 2026-03-11 | 2026-03-13 | $225.00 | $688K | +0.1% | +4.5% | +25.0% |
| LGND | SELL | 2026-03-04 | 2026-03-06 | $205.83 | $2.8M | +3.9% | +1.0% | +17.0% |
| LGND | SELL | 2025-12-12 | 2025-12-16 | $188.31 | $679K | +1.4% | +1.9% | +7.9% |
| LGND | BUY | 2025-05-09 | 2025-05-13 | $104.06 | $156K | -5.5% | +6.5% | +36.7% |
| LGND | SELL | 2025-03-04 | 2025-03-06 | $115.03 | $575K | -7.5% | -13.4% | -9.6% |
| LGND | SELL | 2024-12-23 | 2024-12-26 | $116.37 | $490K | -2.0% | +3.9% | -4.2% |
| LGND | SELL | 2024-09-20 | 2024-09-24 | $103.94 | $133K | +5.7% | +11.9% | +14.8% |
| LGND | SELL | 2024-05-15 | 2024-05-17 | $86.29 | $2.1M | -2.2% | -6.1% | +20.1% |
| LGND | SELL | 2024-02-28 | 2024-02-29 | $88.46 | $12K | -9.6% | -8.1% | +6.1% |
| LGND | SELL | 2022-11-09 | 2022-11-10 | $75.64 | $257K | -7.9% | -20.3% | -12.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.